ITMCTR2200005592Not yet recruiting未知
Effectiveness and safety of Yizhiqingxin Formula in treating patients with vascular dementia(stasis toxin syndrome)
Xiyuan Hospital,China Academy of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 45 to 75 (—)
- Sex
- All
Inclusion Criteria
- •Diagnostic criteria:
- •? American Psychiatric Association Diagnostic Manual and Statistical Manual of Mental Disorders Standard (DSM-IV);
- •?2002 Chinese Medical Association Neurology Branch Draft Diagnostic Criteria for Vascular Dementia.
- •?Age =45 years old and =75 years old, both male and female; women should be postmenopausal women who are infertile.
- •?Meet the above diagnostic criteria for dementia, VD diagnostic criteria and TCM syndrome diagnostic criteria, and the course of dementia is more than 3 months.
- •? The degree of CDR dementia was assessed as mild and moderate dementia (CDR=1.0, 2.0).
- •? Mini-Mental State Examination Scale (MMSE) = 26 points, = 10 points.
- •?HIS points = 7 points.
- •? Volunteers and signed informed consent.
- •? Have a correct understanding of the significance of drug research, and have good compliance with the observation and evaluation of researchers.
- •? Have a certain degree of education, can read simple newspaper articles and write simple small articles in the past.
Exclusion Criteria
- •? Alzheimer's disease patients with HIS score =4 points and mixed dementia patients with 5-6 points.
- •? Patients with dementia and depression were excluded.
- •? Patients with CDR=3.0.
- •? Dementia patients after cerebral hemorrhage or large cortical infarction.
- •? Those with severe neurological deficits.
- •? Patients with severe heart, liver and kidney function.
- •? Patients who have used any history of drugs that may affect cognitive function in the past 3 months.
Investigators
Similar Trials
Completed
Not Applicable
Efficacy and safety of Yijin-tang on polycystic ovarian syndrome: A single-arm pilot studyEndocrine, nutritional and metabolic diseaseKCT0002749Kyung Hee University Oriental Medicine Hospital at Gangdong15
Not yet recruiting
Phase 1
Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003243Beijing University of Chinese Medicine Third Affiliated Hospital
Not yet recruiting
Not Applicable
Clinical efficacy evaluation of Jingxin Zhidong recipe in the treatment of children with tic disorder and its correlation with allergic indexesTic Disorder (TD)ITMCTR2100005032Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Completed
Not Applicable
Clinical efficacy evaluation of Jingxin Zhidong formula in the treatment of moderate and severe Tic DisorderITMCTR2100004402Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not yet recruiting
Phase 4
Efficacy and Safety Evaluation of Yangxin Dawaimixike Migao in the Treatment of Chronic Stable Angina Pectoris (Qi Stagnation and Blood Stasis Syndrome): A block randomized, double-blind, double&#Chronic Stable Angina Pectoris (Qi Stagnation and Blood Stasis Syndrome)ITMCTR2000002927Guang'anmen Hospital, China Academy of Chinese Medical Sciences
